SCHEMBL7209064

SCHEMBL7209064

CCCCOC(=O)Nc1ccc(C(=O)O)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.76
NPC1 O15118 8/20 0.76
SMN1; SMN2 Q16637 8/20 0.76
CASP1 P29466 1/20 0.76
HPGD P15428 6/20 0.67
MAPT P10636 3/20 0.67
ALDH1A1 P00352 2/20 0.67
MAPK1 P28482 2/20 0.67
KDM4E B2RXH2 1/20 0.67
MCL1 Q07820 1/20 0.67
L3MBTL1 Q9Y468 1/20 0.67
CSNK2A2 P19784 3/20 0.61
CSNK2A1 P68400 3/20 0.61
RECQL P46063 1/20 0.60
LMNA P02545 1/20 0.59
TP53 P04637 2/20 0.59
NFKB1 P19838 1/20 0.59
NFKB2 Q00653 1/20 0.59
KMT2A Q03164 1/20 0.59
RELA Q04206 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22441244 0.95 RAB9A (0.69) RAB9ANPC1SMN1; SMN2CASP1HPGD
SCHEMBL28735058 0.94 NPC1 (0.68) RAB9ANPC1SMN1; SMN2CASP1HPGD
SCHEMBL7564852 0.90 RAB9A (0.79) RAB9ANPC1SMN1; SMN2CASP1HPGD
SCHEMBL29893174 0.88 RAB9A (0.76) RAB9ANPC1SMN1; SMN2CASP1HPGD
SCHEMBL10943133 0.88 RAB9A (0.86) RAB9ANPC1SMN1; SMN2CASP1HPGD
SCHEMBL7564856 0.87 RAB9A (0.70) RAB9ANPC1SMN1; SMN2CASP1HPGD
SCHEMBL8132597 0.86 RAB9A (1.00) RAB9ANPC1SMN1; SMN2CASP1HPGD
SCHEMBL30918894 0.85 SMN1; SMN2 (0.68) RAB9ANPC1SMN1; SMN2CASP1HPGD
SCHEMBL13387589 0.85 RAB9A (0.72) RAB9ANPC1SMN1; SMN2CASP1HPGD
SCHEMBL3765824 0.85 RAB9A (0.69) RAB9ANPC1SMN1; SMN2CASP1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0921122-B1 EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF TAIHO PHARMACEUTICAL CO LTD (JP) 2003-05-21 EP disclosed
US-6110967-A USEFUL AS AGENTS FOR PREVENTING AND TREATING METABOLIC OSTEOPATHY SUCH AS OSTEOPOROSIS, HYPERCALCEMIA AND BONE METASTASIS OF CANCER BECAUSE THEY SPECIFICALLY INHIBITS CATHEPSIN L AND ITS FAMILY ENZYMES TO INHIBIT BONE RESORPTION TAIHO PHARMACEUTICALS CO., LTD. (JP) 2000-08-29 US disclosed
EP-0921122-A1 NOVEL EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) 1999-06-09 EP disclosed